Minutes from Stakeholder Meeting on MDUFA III Reauthorization, February 28, 2012

Stakeholder Meeting on MDUFA III Reauthorization February 28, 2012, 1:30 – 3:15 PM HHS Humphrey Building, Washington, DC Room 305A Purpose To provide a status update of the ongoing MDUFA III negotiations. Participants FDA Malcolm Bertoni Office of the Commissioner (OC) Ashley Boam Center for Devices and Radiological Health (CDRH) Nathan Brown Office of Chief…

Flebogamma DIF 5%

<!– –> <!– Page Last Updated: 03/15/2012 –> Page Last Updated: 03/15/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Postmarketing Requirements and Commitments: Reports

<!– –> <!– Page Last Updated: 03/13/2012 –> Page Last Updated: 03/13/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

PMA Final Decisions for January 2012

<!– –> <!– Page Last Updated: 03/13/2012 –> Page Last Updated: 03/13/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Class I Medical Device Recall: Acclarent Inspira AIR Balloon Dilation System, size 18X40mm.

Recall Class: Class I Date Recall Initiated: January 30, 2012. Product: Acclarent Inspira AIR Balloon Dilation System, size 18x40mm, product code BC1840A, manufactured between March 2011 and June 2011. Use: The Inspira AIR Balloon Dilation System is an airway balloon catheter intended to dilate and restore airflow to a patient’s airways. Recalling Firm: Acclarent, Inc….

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Anuncio de seguridadInformación adicional para pacientesInformación adicional para profesionales de la saludResumen de datosLimitaciones en la dosis de estatinasReferencias Anuncio de seguridad El 1º de marzo del 2012, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) emitió recomendaciones actualizadas sobre la interacción entre medicamentos para el virus de…